Healthcare / Medical Care FacilitiesTokyo
$632.00
-15.00 (-2.32%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 35% · confianza 12%
FCF escenarios
weak_data · normalized FCF $1.0B · quality 31.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
30/100
D
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.1B
P/E
6.8x
↓EV/EBITDA
6.6x
↓ROE
15.0%
↑Gross Margin
16.4%
↓Debt/Equity
2.54
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2025 · 4 años de histórico normalizado
Revenue CAGR
+8.5%
FCF CAGR
—
FCF margin
8.0%
FCF / Net income
2.46x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $13.07B · net income $421.9M · FCF $1.04B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $13.07B | $13.07B | $11.82B | $10.82B | $9.43B |
| Net Income | $421.9M | $421.9M | $353.3M | $-506.1M | $-65.2M |
| EBITDA | $1.35B | $1.35B | $1.31B | $651.2M | $703.1M |
| EPS | 64.36 | 64.36 | 56.68 | -90.17 | -12.04 |
| Gross Margin | 16.4% | 16.4% | 14.7% | 12.4% | 11.1% |
| Operating Margin | 5.6% | 5.6% | 4.5% | 0.7% | -4.6% |
| Net Margin | 3.2% | 3.2% | 3.0% | -4.7% | -0.7% |
| Balance Sheet | |||||
| Debt/Equity | 2.54 | 2.54 | 4.50 | 6.47 | 6.23 |
| Current Ratio | 0.79 | 0.79 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.04B | $1.04B | $1.19B | $-15.1M | $-555.6M |
| Returns | |||||
| ROE | 15.0% | 15.0% | 20.2% | -37.7% | -4.6% |
| Valuation | |||||
| P/E | 6.83 | 6.83 | 12.06 | — | — |
| EV/EBITDA | 6.64 | 6.64 | 7.97 | 14.76 | 12.82 |
| P/B | 1.47 | 1.47 | 2.44 | 1.67 | 1.37 |
| Growth & Yield | |||||
| Revenue Growth | 10.6% | 10.6% | 9.2% | 14.7% | — |
| EPS Growth | 13.5% | 13.5% | 162.9% | -649.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-4.5%
EPS terminal req.
$56.08
Spread vs growth
18.0%
5Y implied EPS CAGR
1.1%
EPS terminal req.
$67.86
Spread vs growth
12.5%
10Y implied EPS CAGR
5.4%
EPS terminal req.
$109.28
Spread vs growth
8.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-51.4%
Start / end P/E
23.0x → 9.8x
EPS bridge
56.68 → 64.36
Residual
-7.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.